Canada: The new use of sodium-glucose cotransporter-2 (SGLT2) inhibitors compared with dipeptidyl peptidase 4 (DPP-4) inhibitors confers 20% lower dementia risk in older people with type 2 diabetes, a.
E-Mail
DALLAS, Jan. 25, 2021 The continued global burden of stroke and how it disproportionately affects women are highlighted in new science published online today in the February issue of
Stroke, a journal of the American Stroke Association, a division of the American Heart Association.
Stroke editors selected nine manuscripts focused on stroke disparities in women in this collaboration with Go Red for Women®, the Association s global movement to end heart disease and stroke in women. Stroke continues to be a leading cause of death and disability worldwide, with women being more adversely affected by the global burden of stroke, said Stroke Editor-In-Chief Ralph L. Sacco, M.D., M.S., FAHA, a past president of the American Heart Association. As our population ages, the number of stroke survivors will continue to rise, especially among women. We must include more women in stroke research so we can enhance the critical evidence necessary to provide the appropriate stroke